# Diindolylmethane in Preventing Cancer in Healthy Volunteers

> **NCT00784394** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 20 (actual)

## Conditions studied

- Healthy, no Evidence of Disease

## Interventions

- **DRUG:** diindolylmethane
- **OTHER:** placebo
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis
- **OTHER:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00784394
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784394, "Diindolylmethane in Preventing Cancer in Healthy Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00784394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*